Sapphire Therapeutics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Investors
  • 1

Sapphire Therapeutics General Information

Description

Operator of biopharmaceutical company. The company develops and commercialize compounds that are ready for clinical or preclinical testing in oncologic and metabolic diseases.

Contact Information

Formerly Known As
Rejuvenon Corp
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1031 United States Highway 22
  • Suite 303
  • Bridgewater, NJ 08807
  • United States
+1 (908)
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Corporate Office
  • 1031 United States Highway 22
  • Suite 303
  • Bridgewater, NJ 08807
  • United States
+1 (908)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sapphire Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 28-Jan-2009 Completed Clinical Trials - Phase 2
3. Later Stage VC 14-Jun-2006 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series B) 12-Sep-2005 $40M $52M Completed Clinical Trials - Phase 2
1. Early Stage VC (Series A) 01-Apr-2001 $12M $12M Completed Product Development
To view Sapphire Therapeutics’s complete valuation and funding history, request access »

Sapphire Therapeutics Patents

Sapphire Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20070191283-A1 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues Inactive 12-Aug-2004
US-20160046667-A1 Crystal forms of anamorelin Active 29-Jun-2004
US-9975921-B2 Crystal forms of anamorelin Inactive 29-Jun-2004
US-20070004638-A1 Form c dihydrates; useful as they act directly on the pituitary gland cells to release growth hormone; storage stability Active 29-Jun-2004
US-7825138-B2 Form c dihydrates; useful as they act directly on the pituitary gland cells to release growth hormone; storage stability Active 29-Jun-2004 C07K5/0202
To view Sapphire Therapeutics’s complete patent history, request access »

Sapphire Therapeutics Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
BCM Ventures Venture Capital Minority
BankInvest Biotech Ventures Venture Capital Minority
Baylor College of Medicine University Minority
Boston Millennia Partners Venture Capital Minority
Burrill & Co Merchant Banking Firm Minority
You’re viewing 5 of 11 investors. Get the full list »

Sapphire Therapeutics FAQs

  • When was Sapphire Therapeutics founded?

    Sapphire Therapeutics was founded in 2000.

  • Where is Sapphire Therapeutics headquartered?

    Sapphire Therapeutics is headquartered in Bridgewater, NJ.

  • What industry is Sapphire Therapeutics in?

    Sapphire Therapeutics’s primary industry is Biotechnology.

  • Is Sapphire Therapeutics a private or public company?

    Sapphire Therapeutics is a Private company.

  • What is Sapphire Therapeutics’s current revenue?

    The current revenue for Sapphire Therapeutics is .

  • How much funding has Sapphire Therapeutics raised over time?

    Sapphire Therapeutics has raised $59.5M.

  • Who are Sapphire Therapeutics’s investors?

    BCM Ventures, BankInvest Biotech Ventures, Baylor College of Medicine, Boston Millennia Partners, and Burrill & Co are 5 of 11 investors who have invested in Sapphire Therapeutics.

  • When was Sapphire Therapeutics acquired?

    Sapphire Therapeutics was acquired on 28-Jan-2009.

  • Who acquired Sapphire Therapeutics?

    Sapphire Therapeutics was acquired by Helsinn Healthcare.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process